Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine

Diabetologia. 2010 Jan;53(1):206-8. doi: 10.1007/s00125-009-1535-0. Epub 2009 Sep 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cohort Studies
  • Confounding Factors, Epidemiologic
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / adverse effects
  • Insulin / analogs & derivatives*
  • Insulin / therapeutic use
  • Insulin Glargine
  • Insulin Resistance / physiology*
  • Insulin, Long-Acting
  • Neoplasms / chemically induced*
  • Neoplasms / epidemiology
  • Risk Factors
  • Safety

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • Insulin Glargine